Abiopharma

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Change of Interest of Substantial Shareholder/Director - Lim Yong Sheng

A request for approval of a class action was filed against the bank regarding the collection of a fee for investment consulting services.

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Change of Interest of Substantial Shareholder/Director - Lim Yong Guan

Genesco Names Jonathan Collins Chief Financial Officer

General Announcement: Resignation of Director and changes to the composition of Board Committees

Kite Realty Group Announces Proposed Private Offering of $300 Million of Exchangeable Senior Notes

Merck Announces New Agreement with ADAP Crisis Task Force to Improve Access and Care for People Living with HIV

Bullish receives Gibraltar Financial Services Commission approval to offer trading in tokenized securities

Ring Energy Joins Russell 3000® Index

Merck Announces New Agreement with ADAP Crisis Task Force to Improve Access and Care for People Living with HIV